Phaarmasia Limited Company Profile

08:07 EDT 20th March 2018 | BioPortfolio

As one of India's premier pharmaceutical contract (toll) manufacturing & marketing companies, following strict GMP (Good Manufacturing Practices) guidelines, we invite you to explore our web site and acquaint yourself with the services and the range of products that we offer.The logo of Phaarmasia has been evolved on the basis of the Chinese symbol "Yin-Yang". According to Taoism, the universe is composed of two elementary forces-the active masculine/positive force and the passive/feminine force. Whoever can have these forces in equal quantities will achieve perfect harmony.Using this as the principle idea and taking the essence from this, the logo of Phaarmasia has been adopted. The two elements which are linked together in our logo represent the two forces respectively. This fusion of two forces radiates harmony & continuity and perennial happiness.Phaarmasia's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft. It is a diversified, multi-locational, multi-product group which has been promoted by professionals who have been associated with the pharmaceutical industry in India for the last 40 years. In addition to the information provided on our website, additional information can be obtained directly from us.Our D-U-N-S registration number is 65-014-6970 Mission Statement n the never ending quest for quality, we dedicate ourselves to exceed expectations at all times as it provides us with greatest competitive edge.Our motto is to deliver to our customers superior quality products which give consumers the fullest satisfaction. We commit ourselves, as a corporation and as individuals to "DO IT RIGHT FIRST TIME, EVERY TIME" and to achieve this we have an environment that encourages our people, since "people make the difference". Quality always occupies a special place and quality consciousness is a value we up-hold in every facet of manufacturing. Pursuit of quality is a continuous on-going exercise and our corporate credo is "TO BETTER THE BEST".


16,Phase III, I.D.A Jeedimetla
Andhra Pradesh
500 055


Phone: 91-40-3095002
Fax: 91-40-3097323

News Articles [30 Associated News Articles listed on BioPortfolio]

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [82 Associated Companies listed on BioPortfolio]

Phaarmasia Limited

As one of India's premier pharmaceutical contract (toll) manufacturing & marketing companies, following strict GMP (Good Manufacturing Practices) guidelines, we invite you to explore our web site and ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...



VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Phaarmasia Limited" on BioPortfolio

We have published hundreds of Phaarmasia Limited news stories on BioPortfolio along with dozens of Phaarmasia Limited Clinical Trials and PubMed Articles about Phaarmasia Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phaarmasia Limited Companies in our database. You can also find out about relevant Phaarmasia Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record